Renata Company Description
Renata PLC manufactures, markets, and distributes pharmaceuticals, animal health medicines, oncology-based, agro-based, poultry, and consumer products in Bangladesh.
The company offers generic products, including amantadine, clindamycin, clindamycin, colchicine, dipyridamole, escitalopram, fludrocortisone acetate, hydrocortisone, prednisolone, propylthiouracil, sertraline hydrochloride, terbinafine, and topiramate tablet and capsules.
It also offers specialty products, such as SHK-024, an antidepressant, and SHK 007, to reduce toxicity in pediatrics.
In addition, it provides animal health products. The company was formerly known as Pfizer Laboratories (Bangladesh) Limited and changed its name to Renata Limited in 1993.
Renata PLC was incorporated in 1972 and is headquartered in Dhaka, Bangladesh.
| Country | Bangladesh |
| Founded | 1972 |
| Industry | Pharmaceutical Preparations |
| Employees | 8,366 |
| CEO | Syed S. Kabir |
Contact Details
Address: Plot No. 1 Dhaka, 1216 Bangladesh | |
| Phone | 880 2 800 1450 |
| Website | renata-ltd.com |
Stock Details
| Ticker Symbol | RENATA |
| Exchange | Dhaka Stock Exchange |
| Fiscal Year | July - June |
| Reporting Currency | BDT |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Syed S. Kabir | Chief Executive Officer |
| Mustafa Aolad | Chief Financial Officer |